Market Overview:
The global chemiluminescence immunoassay devices market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing prevalence of infectious diseases, rising demand for early diagnosis and treatment, and technological advancements in chemiluminescence immunoassay devices. Based on type, the global chemiluminescence immunoassay devices market is segmented into reagents & kits, analyzers, software, and services. The reagents & kits segment is expected to account for the largest share of the global chemiluminescence immunoassay devices market in 2018. This can be attributed to their growing use in laboratory settings for performing various tests such as ELISA (enzyme-linked immunosorbent assay) and Western blotting. Based on application, the global chemiluminescence immunoassay devices market is segmented into infectious diseases, endocrinology, oncology,, and others (cardiology/pulmonology/neurology).
Product Definition:
Chemiluminescence Immunoassay Devices are used to detect the presence of antibodies in a sample. They are important because they can be used to quickly and accurately diagnose diseases.
Reagents & Kits:
Reagents & kits are the most important factor in any chemiluminescence immunoassay devices market. Reagents and kits are used by manufacturers, suppliers, and end-users during the production process of any chemiluminescence immunoassay device. The growth factor for this market is increasing demand for advanced diagnostic techniques due to growing prevalence of chronic diseases such as cancer, diabetes mellitus which leads to rise in demand for accurate and effective diagnostic procedures.
Analyzers:
An analyzers is a tool that is used to measure and analyze different types of substances. In chemiluminescence immunoassay devices an analyzer measures the amount of light produced by the chemical reaction between the test sample and labeled antibody. The most commonly used analyzers are liquid scintillators, photomultiplier tubes (PMTs), electrochemical cells, crystal detectors, and optical fibers.
Application Insights:
Infectious diseases segment dominated the global chemiluminescence immunoassay devices market in 2017. This is attributed to a rise in prevalence of infectious diseases, such as HIV, tuberculosis, and influenza. Furthermore, increasing number of R&D initiatives by major players for development of novel reagents and kits for diagnosis of infectious diseases is expected to drive the market over the forecast period.
Oncology application segment is anticipated to witness lucrative growth during the forecast period owing to increase in cancer cases globally. For instance, according with WHO statistics published on 22 November 2016 around 1 million people died due to cancer worldwide while around 2.7 million new cases were diagnosed which represented an increase of around 1% from 2015 till date globally (1). Thus increased incidence coupled with rising awareness about early diagnosis are expected fuel demand for CIGIAs during the forecast period thereby driving this segment further contributing towards overall growth during future years.
Regional Analysis:
North America dominated the global chemiluminescence immunoassay devices market in 2017. This can be attributed to the presence of a large number of players, high R&D investment by companies, and well-established healthcare infrastructure. Moreover, increasing demand for point-of-care tests is also expected to drive regional growth over the forecast period.
Infectious diseases are one of the major causes of morbidity throughout the world.
Growth Factors:
- Increasing demand for rapid and accurate diagnostic tests
- Technological advancements in chemiluminescence immunoassay devices
- Growing prevalence of chronic diseases that require frequent monitoring
- Rising demand for point-of-care testing devices
- Increasing number of collaborations and partnerships between diagnostic companies and research institutes
Scope Of The Report
Report Attributes
Report Details
Report Title
Chemiluminescence Immunoassay Devices Market Research Report
By Type
Reagents & Kits, Analyzers, Software, Services
By Application
Infectious Diseases, Endocrinology, Oncology, Others
By Companies
F.Hoffmann-La Roche Ltd, Siemens AG, Abbott Laboratories, Beckman Coulter, Ortho-Clinical Diagnostics, BioMerieux SA, Maccura Biotechnology Co., Ltd., Mindray Medical, Autobio, F.Hoffmann-La Roche Ltd
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
209
Number of Tables & Figures
147
Customization Available
Yes, the report can be customized as per your need.
Global Chemiluminescence Immunoassay Devices Market Report Segments:
The global Chemiluminescence Immunoassay Devices market is segmented on the basis of:
Types
Reagents & Kits, Analyzers, Software, Services
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Infectious Diseases, Endocrinology, Oncology, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- F.Hoffmann-La Roche Ltd
- Siemens AG
- Abbott Laboratories
- Beckman Coulter
- Ortho-Clinical Diagnostics
- BioMerieux SA
- Maccura Biotechnology Co., Ltd.
- Mindray Medical
- Autobio
- F.Hoffmann-La Roche Ltd
Highlights of The Chemiluminescence Immunoassay Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Reagents & Kits
- Analyzers
- Software
- Services
- By Application:
- Infectious Diseases
- Endocrinology
- Oncology
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Chemiluminescence Immunoassay Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Chemiluminescence immunoassay devices are used to measure the levels of a particular chemical in a sample. The device uses light to detect and quantify the amount of the chemical present in the sample.
Some of the major players in the chemiluminescence immunoassay devices market are F.Hoffmann-La Roche Ltd, Siemens AG, Abbott Laboratories, Beckman Coulter, Ortho-Clinical Diagnostics, BioMerieux SA, Maccura Biotechnology Co., Ltd., Mindray Medical, Autobio, F.Hoffmann-La Roche Ltd.
The chemiluminescence immunoassay devices market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Chemiluminescence Immunoassay Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Chemiluminescence Immunoassay Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Chemiluminescence Immunoassay Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Chemiluminescence Immunoassay Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Chemiluminescence Immunoassay Devices Market Size & Forecast, 2020-2028
4.5.1 Chemiluminescence Immunoassay Devices Market Size and Y-o-Y Growth
4.5.2 Chemiluminescence Immunoassay Devices Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Reagents & Kits
5.2.2 Analyzers
5.2.3 Software
5.2.4 Services
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Infectious Diseases
6.2.2 Endocrinology
6.2.3 Oncology
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Chemiluminescence Immunoassay Devices Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Chemiluminescence Immunoassay Devices Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Reagents & Kits
9.6.2 Analyzers
9.6.3 Software
9.6.4 Services
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Infectious Diseases
9.10.2 Endocrinology
9.10.3 Oncology
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Reagents & Kits
10.6.2 Analyzers
10.6.3 Software
10.6.4 Services
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Infectious Diseases
10.10.2 Endocrinology
10.10.3 Oncology
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Reagents & Kits
11.6.2 Analyzers
11.6.3 Software
11.6.4 Services
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Infectious Diseases
11.10.2 Endocrinology
11.10.3 Oncology
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Reagents & Kits
12.6.2 Analyzers
12.6.3 Software
12.6.4 Services
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Infectious Diseases
12.10.2 Endocrinology
12.10.3 Oncology
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Reagents & Kits
13.6.2 Analyzers
13.6.3 Software
13.6.4 Services
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Infectious Diseases
13.10.2 Endocrinology
13.10.3 Oncology
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Chemiluminescence Immunoassay Devices Market: Competitive Dashboard
14.2 Global Chemiluminescence Immunoassay Devices Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 F.Hoffmann-La Roche Ltd
14.3.2 Siemens AG
14.3.3 Abbott Laboratories
14.3.4 Beckman Coulter
14.3.5 Ortho-Clinical Diagnostics
14.3.6 BioMerieux SA
14.3.7 Maccura Biotechnology Co., Ltd.
14.3.8 Mindray Medical
14.3.9 Autobio
14.3.10 F.Hoffmann-La Roche Ltd
